Cartesian Therapeutics, Inc. — Director's Dealing 2026

Jan 8, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cartesian Therapeutics, Inc. (RNAC)
CIK: 0001453687
Period of Report: 2026-01-06

Reporting Person: Miljkovic Milos (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-06	Common Stock	S	3573	$6.8197	Disposed	58820	Direct

Footnotes

F1: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.